Etoricoxib
Etoricoxib (MK-0663) selectively inhibited COX-2 in human whole blood assays in vitro, with an IC50 value of 1.1 ± 0.1 μM for COX-2 (LPS-induced prostaglandin E2 synthesis), compared with an IC50 value of 116 ± 8 μM for COX-1 (serum thromboxane B2 generation after clotting of the blood) .
Product Specifications
CAS Number
202409-33-4
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
358.84
Molecular Formula
C18H15ClN2O2S
Notes
Research use only, not for human use.
Receptor
COX
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog